Gavreto Prescribing & Dosing Schedule

Dosage & Administration Drug label Prior authorization Pharmacy Financial assistance Patient education People also ask

Gavreto(pralsetinib)

GAVRETO 100 MG Oral Capsule

NO BOXED WARNING

Dosage & Administration

* Select patients for treatment with GAVRETO based on the presence of a RET gene fusion.
* The recommended dosage in adults and pediatric patients 12 years and older is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking GAVRETO).

drug label

Gavreto Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

prior authorization

Gavreto Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Benefits investigation

Gavreto Enrollment & Patient Assistance Form

pharmacy

Gavreto Preferred Pharmacy

Pharmacy List

financial assistance

Gavreto Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

Gavreto Enrollment & Patient Assistance Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Gavreto Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Gavreto Fact Sheet

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Gavreto FAQs

How is the dosage of Gavreto?Gavreto is available in 1 dosages, including 100 mg Cap

What does Gavreto treat?Gavreto treats Non-Small-Cell Lung Carcinoma

What is Gavreto made of?Gavreto contains pralsetinib which is a Kinase Inhibitor

How Is Gavreto Administered?Gavreto is administered as a Oral Pill

What Are The Gavreto Mechanism Of Action?Gavreto mechanism of action is Rearranged during Transfection (RET) Inhibitors

FAQ Data Source

Dosage & Administration

Dosage & Administration

drug label

Gavreto Prescribing Information

prior authorization

Gavreto Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

pharmacy

Gavreto Preferred Pharmacy

financial assistance

Gavreto Financial Assistance Options

Copay savings program

Bridge program

Foundation programs

patient education

Gavreto Patient Education

Patient toolkit

people also ask

Gavreto FAQs